Drug agency Sanofi India on Thursday reported a web revenue of Rs 131 crore for the third quarter ended September 2022.
The corporate had posted a web revenue of Rs 530 crore within the July-September quarter of final 12 months, the corporate mentioned in a regulatory submitting.
The drug agency follows a January-December monetary 12 months.
Income from operations stood at Rs 692 crore within the interval beneath overview. The identical stood at Rs 754 crore within the corresponding interval earlier 12 months.
The corporate mentioned the results of the September quarter weren’t comparable with the identical quarter final 12 months because it had transferred its nutraceuticals enterprise to Common Nutriscience, enabling a acquire of Rs 489 crore.
(Solely the headline and film of this report could have been reworked by the Enterprise Commonplace employees; the remainder of the content material is auto-generated from a syndicated feed.)